Allscripts reboots to weather the storm
Clients, analysts take wait-and-see stance
CHICAGO – It’s not business as usual, but more like rebooting at Allscripts headquarters now that the waves are beginning to settle after what some market analysts described as a “dismal” quarter for the electronic health record company.
Not only did it post record low earnings, but also it lost its CFO to another company, fired its chairman and three other board members left with him in solidarity. To top it off, stock price plunged as much as 43 percent.
Left steering the ship is CEO Glen Tullman, who has been at the helm for 15 years, veering off course only recently, the result of a troubled merger with Eclipsys in 2010, customers say. The merger gave Allscripts, which had until then been focused solely on the ambulatory care market, ready entry into the acute care space. With the merger came challenges with integration – both product integration and melding of two company cultures.
The company has not given a reason for firing its board chairman, Phil Pead, who came to Allscripts as part of the Eclipsys deal, and Tullman diverts the question, saying: “My focus today is all about our clients, how we help them improve healthcare, and ensuring we execute against our priorities.” Tullman says Allscripts is well positioned to succeed. “We have the right leadership team in place and have made the investments to enable us to lead the industry.” (See a Q&A with Tullman on Page 38).
Tullman boasts that Allscripts customers are a loyal bunch.
Perhaps one of the most loyal is John Bosco, CIO of North Shore-Long Island Jewish Health System, self-described as “the largest Allscripts customer by orders of magnitude.”
“What I see bodes well for the future,” Bosco says. “In the end it will enable Glenn to make the changes that are needed.”
“Glen is severely challenged yet a strong leader,” says Bill Spooner, CIO at Sharp Healthcare in San Diego. Sharp has deployed Allscripts EHRs on the ambulatory side, with Cerner system in place in acute care. “Stay tuned for a hot summer,” adds Spooner, who admits to being concerned.
Charles Christian, CIO at Good Samaritan Hospital, a 232-bed hospital in Vincennes, Ind., says the recent troubles at Allscripts have him on high alert. Good Samaritan uses Allscripts EHRs for physician practices and McKesson Horizon in the hospital.
“When any of our primary vendors struggle from a corporate standpoint, it kind of raises the hairs on the back of my head,” he says. “It makes me watch very, very carefully.” Christian has observed other mergers over the years – some successful, some failed.
“It’s not an easy task to do all the integration in the manner that they want to do it so they can compete with those vendors that kind of have the single view of the patient record,” he says.
Integration has been a problem for Allscripts, and it was exactly what customers and analysts worried about when the merger was announced in June 2010.
Back then Pead seemed optimistic.
"Given our respective architectures, we believe we'll be able to deliver this integration very quickly,” Pead said then.
Piper Jaffrey analyst Sean Wieland agreed, and he cited the Allscripts nearly seamless merger with Misys in 2008.
During the recent turmoil, though, Wieland was among the analysts who downgraded Allscripts stock from “buy” to “neutral.”
“Any one of these items would be a concern, but all three happening simultaneously leads us to question what else is there that we don't know,” he wrote in an brief at the end of April. He added that a rule of thumb is to downgrade on any CFO turnover.
In the quarterly report, which showed net income down by 54 percent, Tullman blamed lower than expected sales for the poor quarterly showing.
Tullman blamed the results on lower than expected sales and an unfavorable sales mix, which directly impacted revenue and profit. "In addition, our investments in improving client experience and accelerating product development, as well as higher than expected software development expense, also put pressure on our bottom line,’ he added.
Citi analyst George Hill was among the analysts downgrading shares from “buy” to “neutral." The Asssociated Press reported that Hill called the company's quarter "strongly disappointing.”
"Allscripts appears to be losing (market) share faster than originally thought, and the negative leverage from a lack of new software sales is now readily apparent," he wrote. He too speculated that the board departures reflect a power struggle won by Tullman.
The firing of Pead, who joined Allscripts in the Eclipsys/Allcripts merger in June 2010, seems a far cry from expectations of what was once described as a perfect match, giving Allscripts a push into the hospital market.
“I've known Phil for years,” Tullman told Healthcare IT News then. “We both have a healthy degree of respect for each other, and a friendship.”